Catalent Biologics (Catalent), a global contract development and manufacturing organization (CDMO), is a leader in providing comprehensive solutions for life sciences companies of all sizes. Catalent’s 19,000+ employees and approximately 2,500 scientists partner with pharma, biotech, and consumer health companies to optimize product development, launch, and full life-cycle supply for patients around the world.
Malone is the Managing Director of Early Charm and the CEO of SilcsBio, one of the 37 portfolio companies that operate under Early Charm’s novel Venture Studio Model. We recently caught up with Malone to discuss a wide range of topics, including the Venture Studio Model, SilcsBio, and the growing life sciences and technology ecosystem blooming in Baltimore.
A key recent hire at Frederick-based BioFactura was biosimilars and scientific affairs expert Rodeina Challand, who joined the BioFactura team as its new VP of Scientific Affairs in late 2021. We caught up with Challand to discuss her background, the biosimilars market landscape, and why she’s excited about what’s next for BioFactura.
American Gene Technologies recently named Dr. Jeff Boyle as its new Chief Science Officer. Boyle was previously President at Ellume USA where he led the build out of the company’s 180,000 square foot manufacturing facility in Frederick, Maryland that produces the first COVID-19 home self-test to receive an EUA from the FDA.
Just recently, UMBC appointed biotech industry veteran Mark Schenerman as Graduate Program Director in Biotechnology, marking an important milestone for the program as it looks to move into a new phase of innovation and growth. Schenerman is an active UMBC biotech professor, runs his own biotech consulting business, and built an impressive biotech career that included more than two decades at MedImmune, one of the most important biotech companies in the region’s history.
NextCure recently brought on a new Vice President of Human Resources, Stacy Rollinger, SPHR, to lead the human resources function and drive talent acquisition activities. We caught up with Rollinger to discuss her career journey, NXTC’s workplace culture, the company’s talent acquisition approach, and its future hiring goals.
In the context of normal human biology, the microbiome is a collection of microorganisms, including bacteria, fungi, viruses, and other microbes, that reside in various bodily habitats, including our gut. Gary Fanger, Founder, President and Chief Executive Officer of Rockville-based Rise Therapeutics, explains that the microbiome needs to be seen in light of a new organ in the body.
Conexus was launched in 2016, with the goal of providing outsourced commercial operations for pharmaceutical and life sciences companies. Conexus primarily focuses on the small and mid-size market, which has been somewhat ignored by other service providers, Chief Executive Officer and Founder, Akshay Kapadia told BioBuzz.
We caught up with Jeff Caskey of WorkForce Genetics (WFGX), a leading life sciences recruiting search firm, to discuss his professional journey, why recruiting became his passion, and how he’s managed to achieve work-life balance despite the rigorous demands of his profession.
BioBuzz recently spoke with Shannon Biermann, who is a Senior Quality Control Manager of Microbiology at Beltsville, MD-based NextCure, to learn more about how she’s navigated her career in Microbiology QC thus far and how NextCure’s unique company culture helped her to take ownership and propel her career to the next level.